WASHINGTON—U.S. health advisers on Wednesday were weighing whether the overdose-reversal drug naloxone should be made available as an over-the-counter medication to help fight the national opioid crisis. A panel of experts to the Food and Drug Administration will vote on the switch late Wednesday afternoon, following hours of presentations and discussions on whether untrained users…